Wyden still undecided on FDA pick, presses for plans on accelerated drug approvals

President Biden's pick to lead the Food and Drug Administration (FDA) pledged to Sen. Ron Wyden (D-Ore.) that he would crack down on companies that take advantage of the agency's accelerated approval pathway.But in a letter released Friday, the...